HomeInsights52 Week High Stocks

Aarti Drugs Ltd 52 Week High

Aarti Drugs Ltd 52 Week High

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

12.6 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

YEARHIGH

₹ 634.9

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week HIGH of Aarti Drugs Ltd is ₹ 634.9 as of 20 Dec 24 .

Company Fundamentals for Aarti Drugs Ltd

No data available

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 2024427.65
19 Dec 2024431.9
18 Dec 2024433.2
17 Dec 2024436.7
16 Dec 2024443.9
13 Dec 2024444.95
12 Dec 2024446.05
11 Dec 2024453.75
10 Dec 2024444.7
09 Dec 2024455.55

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Aarti Drugs Ltd News Hub

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 202...

Read more

18 Oct 2024 10:48

News

Aarti Drugs gains after arm receives UK MHRA GMP Compliance Certificate

The company said that there are no financial or material impacts as of now. With the GMP c...

Read more

04 Oct 2024 11:09

News

Aarti Drugs' Maharashtra facility gets 7 observations from USFDA

The API inspection was conducted from 12 September to 20 September 2024. At the conclusion...

Read more

21 Sep 2024 14:05

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 2024 08:52

News

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 2024 11:38

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

26 Aug 2024 17:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Aarti Drugs Ltd

What is the significance of Aarti Drugs Ltd reaching its 52-week high?

Aarti Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Aarti Drugs Ltd 52-week high?

Investors monitor Aarti Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Aarti Drugs Ltd a good buy when it hits its 52-week high?

Whether Aarti Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Aarti Drugs Ltd fundamentals.

What should I consider before investing in Aarti Drugs Ltd at its 52-week high?

Before investing in Aarti Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Aarti Drugs Ltd stock price continue to rise after reaching its 52-week high?

Aarti Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions